What happened
Washington University School of Medicine researchers developed an AI classifier distinguishing four common dementia-causing brain diseases: Alzheimer's, Parkinson's, frontotemporal dementia, and dementia with Lewy bodies, alongside healthy brain aging. The tool, using a simple blood draw and 15 blood proteins, achieved 92.3% diagnostic accuracy and identified mixed pathologies, a common clinical challenge. This advancement offers a non-invasive method for precision diagnosis, per Carlos Cruchaga, senior author.
Why it matters
Precision diagnosis for neurodegenerative conditions will accelerate clinical trial patient selection and inform personalised treatment strategies. Clinicians gain a tool to differentiate complex, often co-occurring diseases with high accuracy, improving early intervention pathways. For pharmaceutical companies, this blood-based classifier streamlines patient identification for trials targeting specific disease pathways, a process previously reliant on costly brain scans or spinal taps. This follows earlier research, such as WPI AI's work on predicting Alzheimer's early with accuracy, underscoring a trend towards AI-driven diagnostic improvements in neurology.
